We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results:1-2 of 2

Takeda gives Affymax $10-million milestone payment in anemia drug enterprise
  • Shook Hardy & Bacon LLP
  • USA
  • August 18 2011

California-based Affymax, Inc. has received a $10-million milestone payment from Japan-based Takeda Pharmaceutical Co. to develop and market peginesatide, an investigational drug for the treatment of anemia in chronic renal-failure patients.